Cyclerion Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cyclerion Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Cyclerion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $184K, a 51.5% decline year-over-year.
  • Cyclerion Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $627K, a 82.5% decline year-over-year.
  • Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.07M, a 82.9% decline from 2022.
  • Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.25M, a 35% decline from 2021.
  • Cyclerion Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.61M, a 35.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.07M -$5.19M -82.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $6.25M -$3.36M -35% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $9.61M -$5.38M -35.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $15M -$4.64M -23.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $19.6M +$7.2M +57.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $12.4M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.